THRM GENTHERM Inc Insider Trading

Director Kenneth E Washington buys 1,700 shares of THRM at $28.06 on 2025-05-13, raising stake to 10,965 shares amid -0.9% annual revenue decline.

Kenneth E Washington, a director at Gentherm Inc, purchased 1,700 shares at $28.06, increasing his total holdings from 9,265 shares to 10,965 shares. The transaction occurred at a price 18.3% below the 52-week high of $55.18 and represents a 21.4% gain over the prior 30 days, suggesting a recent uptick in the stock's trajectory. However, the company's fundamentals show caution: annual revenue declined 0.9% year-over-year to $353.9M, and net income was negative at $-128.0K in the latest quarter, despite a market cap of $873.9M. The buy itself is modest in absolute scale—1,700 shares for $47.7K—and does not reflect a major portfolio commitment, warranting monitoring but not immediate escalation.

Director Ronald T Hundzinski buys 5,000 THRM shares at $26.67; stock -49.4% from 52-week high amid flat revenue growth

Hundzinski purchased 5,000 shares at $26.67 on 2025-05-08, increasing his holdings by +38.4% to 18,006 shares. The transaction occurs at a price 49.4% below the 52-week high of $55.18, though the stock has recovered 19.8% over the prior 30 days from a recent low. Gentherm's fundamentals show revenue of $353.9M in the latest quarter with flat annual revenue growth of -0.9% and a net loss of $-128.0K, presenting a context where the director's purchase arrives at depressed valuation levels but amid weak financial momentum. This open-market buy by a director during a price recovery phase, despite stagnant topline performance, warrants tracking to determine whether it reflects management confidence in a turnaround or reflects valuation-driven opportunism at a temporary low.

SVP Thomas Stocker buys 321 shares at $24.96 blended average amid -53.3% YTD decline

Thomas Stocker, SVP and General Manager for Europe at Gentherm Inc, executed 2 separate purchases totaling 321 shares for $8,010.83 on 2025-04-25, at prices ($24.91 and $25.07) near the current market level of $25.76. The stock has declined 53.3% from its 52-week high of $55.18 and fallen 34.5% over the past 90 days, while the company reported a net loss of $128.0K in the latest quarter despite $353.9M in revenue. This transaction represents a modest 1.6% increase in Stocker's holdings from 20.3K to 20.6K shares, suggesting limited incremental commitment relative to his existing position. The purchase occurs at a point of significant price weakness, though it does not definitively indicate conviction given its size relative to both the price decline and the company's recent operational underperformance.

THRM CEO Presley buys 3,000 shares at $24.67; stock -55.3% from 52-week high, -9.9% in 30 days, near technical lows

CEO William T. Presley purchased 3,000 shares at $24.67 on April 25, 2025, increasing holdings from 158,103 to 161,103 shares. The purchase occurs as THRM trades -55.3% from its 52-week high of $55.18 and has declined 9.9% over the past 30 days and 38.4% over 90 days, approaching the low end of its 52-week range at $23.32. Fundamentally, the company reported negative net income of $-128,000 in the latest quarter against $353.9M in quarterly revenue, with annual growth flat at -0.9%. The CEO's cross-ticker track record shows a 100% well-timed rate on 2 prior sales (selling before subsequent declines), but this transaction's significance is moderated by the modest share count increase of 1.9% relative to existing holdings and the lack of information about whether this purchase was discretionary or scheduled.

CEO Eyler sells 29.7K THRM shares at $42.31; holds 147.3K post-sale; stock -26.7% from 52-week high.

Eyler Phillip (President & CEO) sold 29,684 shares for $1,255,930.04 on 2024-11-21, reducing his holdings by 16.8% to 147,317 shares. This is his sixth open-market sale of THRM in the past four months (also sold on 2024-09-19, 2024-09-18, 2024-09-17, 2024-08-06, and 2024-07-11), indicating a sustained pattern of share disposition. His prior five sales at THRM show strong timing outcomes: all resulted in negative 30-day and 90-day returns, with 2 of 2 measurable 90-day outcomes (from August and July) showing declines of -12.2% and -15.7% respectively, consistent with well-timed sell execution. The stock is currently at $43.38, down -26.7% from its $59.18 52-week high but up 7.6% over the last 30 days. Company fundamentals remain solid (revenue $371.5M, +22.0% YoY growth, P/E 19.81), but the CEO's continued reduction of ownership at depressed valuations within this 52-week range deserves monitoring for any material developments not yet disclosed.

THRM CEO Eyler sells 15,000 shares (15.0K) across 3 days for $752,790.98 at $50.19 avg

Phillip Eyler, President & CEO of Gentherm Inc, executed 3 separate sales totaling 15,000 shares for $752,790.98 between September 17–19, 2024, reducing his holdings from 162,317 to 147,317 shares (-9.2%). The trades were executed near the 52-week high of $59.18 (current price $50.78 is -14.2% from that peak), and at a blended average price of $50.19. The company's fundamentals show positive growth (revenue +22.0% annually, $375.7M latest quarter) with a P/E of 23.51, suggesting the stock was not trading at distressed levels at the time of sale. His prior THRM sales show a 2-of-3 well-timed rate at the 90-day mark, and his cross-ticker track record reports 85.71% well-timed sell rate across 9 prior dispositions, though this filing's post-execution price performance cannot yet be fully assessed within traditional measurement windows.

THRM CEO Phillip sold 15,000 shares at $50.03; stock now -23.0% from 52-week high, down 3.0% over 90 days.

Phillip sold 15,000 shares (9.2% of his pre-transaction holdings) at $50.03, leaving him with 147,317 shares. This is his second sell in less than a month at THRM—he previously sold on 2024-07-11 and 2024-06-05 (twice). His cross-ticker track record shows 8 prior open-market sells with a 90-day well-timed rate of 80.00%, suggesting disciplined exit discipline historically. At THRM specifically, his prior sells show mixed outcomes: two June sales declined 9.9% and 10.8% over 30 days (consistent with downside timing), but a May sale gained 6.9% in 30 days before rising another 0.7% by day 90. The stock is currently -23.0% from its 52-week high and has fallen 3.0% over the last 90 days, trading at $49.85 versus his $50.03 sale price. The series of sales within a concentrated timeframe warrants investor attention to whether the CEO perceives deteriorating momentum or is executing a structured reduction in a company that has grown revenue 22.0% annually.

GENTHERM CEO Eyler sells 15,000 shares at $50.40; stock down 22.4% from 52-week high, recent declines offset prior THRM sell timing edge

Phillip Eyler, President & CEO of GENTHERM Inc, sold 15,000 shares (-9.2% of holdings) at $50.40 on 2024-07-11 for $756,000.00. The transaction occurs while the stock is -22.4% from its 52-week high and has declined 3.3% over the past 30 days and 1.2% over 90 days. His prior trades at THRM show 2 of 2 sells were well-timed at the 90-day mark; however, recent activity presents a contrasting pattern: two consecutive sales on 2024-06-05 posted -9.9% and -10.8% returns within 30 days, while an earlier May sale turned positive at +6.9% 30-day return. Against this mixed recent record at THRM and the company's strong fundamentals (annual revenue growth +22.0%, market cap $1.6B), this sale warrants observation to determine whether the timing discipline evident in his prior THRM exits persists.